SCHEMBL5873542

SCHEMBL5873542

CC(C)C(=O)NC1CCN(c2ccc3cc(-c4noc(CCc5ccc(C(F)(F)F)cc5)n4)ccc3n2)C1

nearest known ligand 0.68

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 17/20 0.68
PDE2A O00408 1/20 0.42
CNR1 P21554 1/20 0.41
CNR2 P34972 1/20 0.41
CDK2 P24941 1/20 0.40
AKT1 P31749 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5873523 0.91 MCHR1 (0.58) MCHR1CNR1
SCHEMBL5873546 0.91 MCHR1 (0.56) MCHR1
SCHEMBL5873604 0.83 MCHR1 (0.58) MCHR1CDK2AKT1
SCHEMBL5873559 0.81 MCHR1 (1.00) MCHR1
SCHEMBL5873658 0.78 MCHR1 (0.58) MCHR1CNR1
SCHEMBL5873543 0.72 MCHR1 (1.00) MCHR1
SCHEMBL5873647 0.71 MCHR1 (0.87) MCHR1
Hydrochloric Acid SCHEMBL5873507 0.71 MCHR1 (0.98) MCHR1
SCHEMBL5873522 0.71 MCHR1 (0.87) MCHR1
SCHEMBL5873532 0.71 MCHR1 (0.87) MCHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7084156-B2 2-Aminoquinoline compounds MERCK & CO., INC. (US) 2006-08-01 US claimed
US-20050026915-A1 2-Aminoquinoline compounds MERCK SHARP & DOHME CORP. 2005-02-03 US claimed
EP-1450801-A2 2-AMINOQUINOLINE COMPOUNDS Merck & Co., Inc. (US) 2004-09-01 EP claimed
WO-2003045313-A2 2-AMINOQUINOLINE COMPOUNDS MERCK & CO. INC. (US) 2003-06-05 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050026915-A1 2-Aminoquinoline compounds MCHR1, MCHR2, MC5R MCHR1 1/4885PDE2A 884/4885CNR1 479/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.